Sunshine Biopharma Inc (SBFM)

Currency in USD
1.2000
+0.0100(+0.84%)
Closed·
1.2300+0.0300(+2.50%)
·
Earnings results expected in 14 days
SBFM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.17001.2302
52 wk Range
1.15003.9000
Key Statistics
Prev. Close
1.2
Open
1.17
Day's Range
1.17-1.2302
52 wk Range
1.15-3.9
Volume
8.14K
Average Volume (3m)
55.31K
1-Year Change
-51.0204%
Book Value / Share
5.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBFM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.0000
Upside
+400.00%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Sunshine Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Sunshine Biopharma Inc Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Employees
52

Compare SBFM to Peers and Sector

Metrics to compare
SBFM
Peers
Sector
Relationship
P/E Ratio
−1.0x−2.6x−0.5x
PEG Ratio
−0.010.000.00
Price/Book
0.2x1.8x2.6x
Price / LTM Sales
0.2x6.7x3.3x
Upside (Analyst Target)
-85.3%44.3%
Fair Value Upside
Unlock20.7%4.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.0000
(+400.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Aegis Capital
Buy6.00+400.00%7.00MaintainNov 18, 2025
Aegis Capital
Buy7.00+483.33%15.00MaintainMay 19, 2025

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
-0.19 / -0.09
Revenue / Forecast
9.42M / 12.10M
EPS Revisions
Last 90 days

SBFM Income Statement

People Also Watch

0.9751
UPXI
-7.13%
0.233
CXAI
-1.69%
7.780
KYNB
-0.64%
0.1469
JTAI
+3.38%

FAQ

What Is the Sunshine Biopharma (SBFM) Stock Price Today?

The Sunshine Biopharma stock price today is 1.2000

What Stock Exchange Does Sunshine Biopharma Trade On?

Sunshine Biopharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Sunshine Biopharma?

The stock symbol for Sunshine Biopharma is "SBFM."

What Is the Sunshine Biopharma Market Cap?

As of today, Sunshine Biopharma market cap is 5.89M.

What Is Sunshine Biopharma's Earnings Per Share (TTM)?

The Sunshine Biopharma EPS (TTM) is -1.72.

When Is the Next Sunshine Biopharma Earnings Date?

Sunshine Biopharma will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is SBFM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sunshine Biopharma Stock Split?

Sunshine Biopharma has split 5 times.

How Many Employees Does Sunshine Biopharma Have?

Sunshine Biopharma has 52 employees.

What is the current trading status of Sunshine Biopharma (SBFM)?

As of Feb 11, 2026, Sunshine Biopharma (SBFM) is trading at a price of 1.2000, with a previous close of 1.2000. The stock has fluctuated within a day range of 1.1700 to 1.2302, while its 52-week range spans from 1.1500 to 3.9000.

What Is Sunshine Biopharma (SBFM) Price Target According to Analysts?

The average 12-month price target for Sunshine Biopharma is USD6.0000, with a high estimate of USD6 and a low estimate of USD6. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +400.00% Upside potential.

What Is the SBFM After Hours Price?

SBFM's last after hours stock price is 1.2300, the stock has decreased by 0.0300, or 2.5000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.